KoBioLabs, Inc (KOSDAQ:348150)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,420.00
-250.00 (-5.35%)
At close: Mar 9, 2026
-5.45%
Market Cap 85.83B
Revenue (ttm) 71.83B
Net Income (ttm) -6.55B
Shares Out 19.42M
EPS (ttm) -338.11
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 52,138
Average Volume 121,596
Open 4,310.00
Previous Close 4,670.00
Day's Range 4,255.00 - 4,495.00
52-Week Range 3,730.00 - 7,730.00
Beta 0.61
RSI 34.15
Earnings Date Nov 14, 2025

About KoBioLabs

KoBioLabs, Inc. provides microbiome therapeutics for metabolic, immune, and brain diseases. The company was founded in 2014 and is based in Seoul, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2014
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 348150
Full Company Profile

Financial Performance

In 2024, KoBioLabs's revenue was 68.36 billion, an increase of 106.28% compared to the previous year's 33.14 billion. Losses were -5.30 billion, -61.76% less than in 2023.

Financial Statements

News

There is no news available yet.